Evidence map›Paper›PMID 29916030›Full record

ArticleDer Nervenarzt2018

[The importance of molecular imaging (PET) in the diagnostics of dementia].

M Tscheuschler, M Gebest, F Jessen, A Drzezga

Abstract read
PubMed Publisher
In one paragraph

Article in Der Nervenarzt, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

M TscheuschlerKlinik und Poliklinik für Psychiatrie und Psychotherapie, Uniklinik Köln, Medizinische Fakultät, Kerpener Str. 62, 50924, Köln, Deutschland. Maike.Tscheuschler@uk-koeln.de.
M GebestDeutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Sigmund-Freud-Str. 257, 53127, Bonn, Deutschland.
F JessenKlinik und Poliklinik für Psychiatrie und Psychotherapie, Uniklinik Köln, Medizinische Fakultät, Kerpener Str. 62, 50924, Köln, Deutschland.
A DrzezgaKlinik und Poliklinik für Nuklearmedizin, Uniklinik Köln, Medizinische Fakultät, Kerpener Str. 62, 50924, Köln, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to the expanding older population and increasing prevalence of dementia and currently lacking curative therapy but potentially conceivable availability of molecular-specific treatment to delay the progression of cognitive decline, the early diagnosis of cognitive deficits and their etiological differential diagnosis becomes increasingly more important. The advances in nuclear medicine diagnostics in the field of neurodegenerative diseases within the last few years have been substantial. In this article the relevance of these technologies in the diagnostic process of dementia is described.

Indexed as

DementiaPositron-Emission TomographyAlzheimer DiseaseCognitive DysfunctionHumansAlzheimer’s diseaseAmyloid/TauNuclear medicine diagnosticsPositron emission tomographyProgression delay

Identifiers

PMID29916030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.